Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Non-cash Items (2019 - 2025)

Alx Oncology Holdings' Non-cash Items history spans 4 years, with the latest figure at $59.9 million for Q4 2023.

  • On a quarterly basis, Non-cash Items rose 201.43% to $59.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was $59.9 million, a 201.43% increase, with the full-year FY2023 number at $4.7 million, down 76.32% from a year prior.
  • Non-cash Items hit $59.9 million in Q4 2023 for Alx Oncology Holdings, up from $19.9 million in the prior quarter.
  • Over the last five years, Non-cash Items for ALXO hit a ceiling of $59.9 million in Q4 2023 and a floor of $27000.0 in Q4 2019.
  • Historically, Non-cash Items has averaged $32.4 million across 4 years, with a median of $34.8 million in 2021.
  • Biggest five-year swings in Non-cash Items: plummeted 60.05% in 2022 and later skyrocketed 201.43% in 2023.
  • Tracing ALXO's Non-cash Items over 4 years: stood at $27000.0 in 2019, then surged by 184140.74% to $49.7 million in 2021, then plummeted by 60.05% to $19.9 million in 2022, then skyrocketed by 201.43% to $59.9 million in 2023.
  • Business Quant data shows Non-cash Items for ALXO at $59.9 million in Q4 2023, $19.9 million in Q4 2022, and $49.7 million in Q4 2021.